Heritage and Granules Form Generics Alliance for US Market
Posted on: Friday, 6 July 2007, 12:26 CDT
Heritage Pharmaceuticals and Granules India are teaming up for the development, supply and marketing of generic pharmaceutical products for the US prescription drug market.
Under the agreement, Granules will develop and register selected products for US ANDA submission, and will receive up front and milestone payments. Heritage will retain exclusive sales and marketing rights to such products. Both parties will share net profits from the product sales.
Commenting on the deal, Mr C Krishna Prasad, managing director, said: "This is in line with our overall strategy for partnering with prescription product marketers on a development and manufacturing agreement. We are confident that Heritage will deliver the required market share to make it a mutually profitable business model."
Source: Datamonitor
Related Articles
- Herley Subsidiary is Awarded Contracts for Fast Switching Synthesizers for Use in Embedded System Applications
- Heritage Village Is the Latest Project in the Successful Partnership Between AUI Contractors and the City of Hurst, Texas
- Navilyst Medical Announces Global Debut Today
- Heritage and Banner Sign Generic Product Licensing Agreement
- Heritage and Banner Enter Into Generic Product Licensing Agreement
- Heritage, Ipca Enter Agreement for Generic Pharma Products
- Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
- Adobe Delivers Major Upgrade to FrameMaker
- Heritage and Granules Enter Into Strategic Alliance for the Development, Supply and Marketing of Generic Products for the U.S. Market
- A Fresh Look
 |
 |
User Comments (0)
RSS Feeds